Furthermore, given the wealth of published evidence, we suggest that NKX2-5 mutations do not play a major pathogenic role in thyroid dysgenesis, and that genetic testing of NKX2-5 in TD is not warranted. This evidence concerns the gene NKX2-5 and hypothyroidism, congenital, nongoitrous, 2.